Follow the BioSyent Inc. share price and the full directors' dealings record of the company, a publicly traded company based in Canada. Shares are quoted on the CA market, under the authority of SEDI. Operating in the Health Care sector, BioSyent Inc. has published 77 public disclosures. Market capitalisation: €180.4m. The latest transaction was filed on 28 August 2026 (10 - Acquisition or disposition in the public market). Among the most active insiders: BioSyent Inc.. Every trade is free.
77
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate BioSyent Inc. Strong Buy (bullish), based on 1 analysts. Average price target: CA$18.00.
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,080 of 29,024 companies
73.2
score / 100
Value
57
Quality
89
FCF yld4.8%
Earn yld5.1%
EV/EBITDA13.8x
ROE24%
Gross mgn77%
Net mgn21%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
BioSyent Inc. is a Canadian company focused on the development and commercialization of pharmaceutical products. It aims to provide innovative solutions to enhance patient health.